Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?

doi:10.1183/13993003.01560-2020

Comment

. 2020 Jul 16;56(1):2001560.

doi: 10.1183/13993003.01560-2020. Print 2020 Jul.

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?

Dhamend Lutchman¹

Affiliations

PMID: 32398309
PMCID: PMC7236827
DOI: 10.1183/13993003.01560-2020

Comment

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?

Dhamend Lutchman. Eur Respir J. 2020.

. 2020 Jul 16;56(1):2001560.

doi: 10.1183/13993003.01560-2020. Print 2020 Jul.

Author

Dhamend Lutchman¹

Affiliation

¹ Point Cook, Mebourne, Australia dlutchman@yahoo.com.

PMID: 32398309
PMCID: PMC7236827
DOI: 10.1183/13993003.01560-2020

Abstract

Exogenous supplement of recombinant human (rh)ACE-2 might be a brilliant idea in the treatment of COVID-19. Soluble ACE-2 might impact viral spread, since binding to soluble receptor has been shown to block SARS-CoV-2 entry. https://bit.ly/3bsUKO2

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D. Lutchman has nothing to disclose.

Comment in

Smoking, ACE-2 and COVID-19: ongoing controversies.
Leung JM, Sin DD. Leung JM, et al. Eur Respir J. 2020 Jul 16;56(1):2001759. doi: 10.1183/13993003.01759-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32430431 Free PMC article.

Comment on

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR, Sin DD. Leung JM, et al. Eur Respir J. 2020 May 14;55(5):2000688. doi: 10.1183/13993003.00688-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32269089 Free PMC article.
COVID-19 and smoking: is nicotine the hidden link?
Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F. Russo P, et al. Eur Respir J. 2020 Jun 4;55(6):2001116. doi: 10.1183/13993003.01116-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32341101 Free PMC article.
COVID-19 and nicotine as a mediator of ACE-2.
Leung JM, Yang CX, Sin DD. Leung JM, et al. Eur Respir J. 2020 Jun 4;55(6):2001261. doi: 10.1183/13993003.01261-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32350104 Free PMC article.

Cited by

Nicotinic receptors as SARS-CoV-2 spike co-receptors?
Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G. Dormoy V, et al. Med Hypotheses. 2022 Jan;158:110741. doi: 10.1016/j.mehy.2021.110741. Epub 2021 Dec 14. Med Hypotheses. 2022. PMID: 34924680 Free PMC article.
Tobacco use as a well-recognized cause of severe COVID-19 manifestations.
Gupta AK, Nethan ST, Mehrotra R. Gupta AK, et al. Respir Med. 2021 Jan;176:106233. doi: 10.1016/j.rmed.2020.106233. Epub 2020 Nov 19. Respir Med. 2021. PMID: 33253975 Free PMC article. Review.
Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.
Shang H, Chang T, Yang W, Shi L, Hu S, Tian L, Ren J, Wang T, Wang J, Guo J, Cui Y. Shang H, et al. BMC Infect Dis. 2024 Jan 2;24(1):36. doi: 10.1186/s12879-023-08947-w. BMC Infect Dis. 2024. PMID: 38166694 Free PMC article.
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile.
Vial P, González C, Icaza G, Ramirez-Santana M, Quezada-Gaete R, Núñez-Franz L, Apablaza M, Vial C, Rubilar P, Correa J, Pérez C, Florea A, Guzmán E, Lavín ME, Concha P, Nájera M, Aguilera X. Vial P, et al. BMC Infect Dis. 2022 Jan 28;22(1):99. doi: 10.1186/s12879-022-07045-7. BMC Infect Dis. 2022. PMID: 35090398 Free PMC article.
Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California.
Young-Wolff KC, Slama N, Alexeeff SE, Sakoda LC, Fogelberg R, Myers LC, Campbell CI, Adams AS, Prochaska JJ. Young-Wolff KC, et al. Nicotine Tob Res. 2023 Jan 5;25(2):211-220. doi: 10.1093/ntr/ntac090. Nicotine Tob Res. 2023. PMID: 35368066 Free PMC article.

See all "Cited by" articles

References

1. Russo P, Bonassi S, Giacconi R, et al. . COVID-19 and smoking: is nicotine the hidden link? Eur Respir J 2020; 55: 2001116. doi:10.1183/13993003.01116-2020 - DOI - PMC - PubMed
1. Leung JM, Yang CX, Sin DD. COVID-19 and nicotine as a mediator of ACE-2. Eur Respir J 2020; 55: 2001261. doi:10.1183/13993003.01261-2020 - DOI - PMC - PubMed
1. Olds JL, Kabbani N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? FEBS J 2020; in press [https://doi.org/10.1111/febs.15303]. doi:10.1111/febs.15303 - DOI - PMC - PubMed
1. Changeux JP, Amoura Z, Rey F, et al. . A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Qeios 2020; preprint [https://doi.org/10.32388/FXGQSB]. doi:10.32388/FXGQSB - DOI - PubMed
1. Berlin I, Thomas D, Le Faou AL, et al. . COVID-19 and smoking. Nicotine Tob Res 2020; in press [https://doi.org/10.1093/ntr/ntaa059]. doi:10.1093/ntr/ntaa059 - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Russo P, Bonassi S, Giacconi R, et al. . COVID-19 and smoking: is nicotine the hidden link? Eur Respir J 2020; 55: 2001116. doi:10.1183/13993003.01116-2020 - DOI - PMC - PubMed

[2] Russo P, Bonassi S, Giacconi R, et al. . COVID-19 and smoking: is nicotine the hidden link? Eur Respir J 2020; 55: 2001116. doi:10.1183/13993003.01116-2020 - DOI - PMC - PubMed

[3] Leung JM, Yang CX, Sin DD. COVID-19 and nicotine as a mediator of ACE-2. Eur Respir J 2020; 55: 2001261. doi:10.1183/13993003.01261-2020 - DOI - PMC - PubMed

[4] Leung JM, Yang CX, Sin DD. COVID-19 and nicotine as a mediator of ACE-2. Eur Respir J 2020; 55: 2001261. doi:10.1183/13993003.01261-2020 - DOI - PMC - PubMed

[5] Olds JL, Kabbani N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? FEBS J 2020; in press [https://doi.org/10.1111/febs.15303]. doi:10.1111/febs.15303 - DOI - PMC - PubMed

[6] Olds JL, Kabbani N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? FEBS J 2020; in press [https://doi.org/10.1111/febs.15303]. doi:10.1111/febs.15303 - DOI - PMC - PubMed

[7] Changeux JP, Amoura Z, Rey F, et al. . A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Qeios 2020; preprint [https://doi.org/10.32388/FXGQSB]. doi:10.32388/FXGQSB - DOI - PubMed

[8] Changeux JP, Amoura Z, Rey F, et al. . A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Qeios 2020; preprint [https://doi.org/10.32388/FXGQSB]. doi:10.32388/FXGQSB - DOI - PubMed

[9] Berlin I, Thomas D, Le Faou AL, et al. . COVID-19 and smoking. Nicotine Tob Res 2020; in press [https://doi.org/10.1093/ntr/ntaa059]. doi:10.1093/ntr/ntaa059 - DOI - PMC - PubMed

[10] Berlin I, Thomas D, Le Faou AL, et al. . COVID-19 and smoking. Nicotine Tob Res 2020; in press [https://doi.org/10.1093/ntr/ntaa059]. doi:10.1093/ntr/ntaa059 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?

Affiliation

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?

Author

Affiliation

Abstract

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous